[ad_1] Eylea, the company’s top-selling blockbuster, isn’t going away soon. [ad_2] Source link
Tag: Biopharmaceuticals
WSJ News Exclusive | New Drugs for Cancer, Rare Disease Can Now Cost More Than $20,000 a Month
[ad_1] WSJ News Exclusive Health Trend follows rising pressure on companies to rein in repeat or annual price hikes for older drugs [ad_2] Source link
The End of AbbVie’s $200 Billion Monopoly Won’t Sink the Stock
[ad_1] The drugmaker is offering steep discounts on its immune-disease therapy Humira to protect market share this year. [ad_2] Source link
WSJ News Exclusive | AbbVie Aims for New Drugs to Boost Sales as Competitors Target Humira
[ad_1] Drugmaker AbbVie Inc. is looking for its next hit. Now that its blockbuster immune-disease therapy Humira is facing lower priced competition, AbbVie is turning to a pair of next-generation…
Drugmakers Raise Prices on Nearly 1,000 Medicines but Show Restraint
[ad_1] Health List prices climb by 5.6% on average as new federal law aims to lower drug costs [ad_2] Source link
U.S. Appeals Court Sides With Drugmakers on Discount Program
[ad_1] Business Health Care Health Drugmakers can limit shipments to hospitals and clinics of drugs discounted under federal program, court rules in loss for hospitals [ad_2] Source link
When Executives Stop Selling Stock, a Big Deal Might Be Ahead
[ad_1] Markets Deals Pause in insider sales can be a clue for investors, past bids show [ad_2] Source link
WSJ News Exclusive | Moderna Considers Price of $110-$130 for Covid-19 Vaccine
[ad_1] WSJ News Exclusive Health Commercial price is similar to Pfizer’s plans for after government contracting ends [ad_2] Source link
Johnson & Johnson Fourth-Quarter Earnings Down 25%
[ad_1] The healthcare-products company reported declining sales in the fourth quarter as demand dropped for its Covid-19 vaccine. [ad_2] Source link